Related Experiment Video

Updated: Sep 13, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

Early immunization of neonates with trivalent oral poliovirus vaccine

L Y Weckx1, B J Schmidt, A A Herrmann

  • 1Escola Paulista de Medicina, São Paulo, Brazil.

Bulletin of the World Health Organization
|January 1, 1992
PubMed

Insights

Early immunization with trivalent oral poliovirus vaccine (TOPV) at birth in Brazil enhances immune response and reduces susceptibility to polio. This early vaccination schedule provides superior protection, especially against poliovirus type 3.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Polio remains a global health concern, necessitating effective vaccination strategies.
  • The trivalent oral poliovirus vaccine (TOPV) is a key tool in polio eradication efforts.
  • Optimizing infant immunization schedules is crucial for achieving herd immunity and preventing disease transmission.

Purpose of the Study:

  • To evaluate the immune response to early immunization with TOPV in Brazilian neonates.
  • To compare the efficacy of two different TOPV immunization schedules.
  • To assess the impact of birth dose vaccination on poliovirus antibody levels and seroconversion rates.

Main Methods:

  • A study involving 85 neonates in São Paulo, Brazil, assigned to two TOPV immunization groups.
  • Group A received TOPV at birth, 2, 4, and 9 months; Group B received TOPV at 2, 4, and 6 months.
  • Sequential blood sample collection from mothers, umbilical cords, and infants for poliovirus neutralizing antibody assays.

Main Results:

  • Infants receiving TOPV at birth (Group A) demonstrated a superior immune response, particularly to poliovirus type 3.
  • By one year of age, only 3.7% of infants in Group A remained susceptible, compared to 25.9% in Group B.
  • Excellent seroconversion rates were achieved from the third dose onward when immunization commenced at birth.

Conclusions:

  • Administering TOPV at birth establishes immunity earlier and elicits a more robust immune response.
  • Early immunization schedules starting at birth significantly reduce the proportion of susceptible individuals.
  • Initiating polio immunization at birth is a highly effective strategy for enhancing seroconversion rates and achieving early protection.

More Related Videos

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...